BioProtect Ltd., a technology platform company, provides innovative bioabsorbable spacers designed to protect healthy organs during radiation therapy. 

Their flagship product, the BioProtect Balloon Implant™ System, is a biodegradable balloon spacer that temporarily positions the anterior rectal wall away from the prostate during radiotherapy for prostate cancer. 

The balloon spacer enables safe high-dose radiation therapy (including dose escalation and hypofractionation), dramatically decreasing the probability of serious and chronic radiation side effects while improving biochemical tumor control.

The company received FDA clearance for its BioProtect Balloon Implant™ System and is currently in sales in the US and EU.